Characterization of hepatic cytochrome P4503A activity in patients with end‐stage renal disease View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2003-05

AUTHORS

Thomas C. Dowling, Andrew E. Briglia, Jeffrey C. Fink, Donna S. Hanes, Paul D. Light, Lucy Stackiewicz, Chetan S. Karyekar, Natalie D. Eddington, Matthew R. Weir, William L. Henrich

ABSTRACT

BACKGROUND: The cytochrome p450 (CYP) oxidative enzyme system, located primarily in the liver and small intestine, is responsible for metabolism and detoxification of numerous endogenous and exogenous substances. The most abundant CYP enzyme, CYP3A, is known to be involved in the metabolism of more than 200 commonly used medications. In experimental models of renal failure, both hepatic function and CYP enzyme content are reduced; however, direct evidence in humans is lacking. Evaluation of drug metabolism in patients with end-stage renal disease is important because these patients use a large number of medications and are at risk of adverse reactions and drug-drug interactions. METHODS: We measured hepatic CYP3A activity at baseline and after rifampin (INN, rifampicin) enzyme induction in 12 patients with end-stage renal disease and 12 healthy, age-matched controls. Hepatic CYP3A phenotype was characterized with the erythromycin breath test, and enzyme induction capacity was evaluated with a short course of rifampin (600 mg/d for 6 days). RESULTS: The end-stage renal disease group had 28% lower baseline erythromycin breath test values than controls (P <.05); however, enzyme induction capacity after rifampin administration was similar between groups (P =.70). CONCLUSION: The findings suggested that one mechanism by which patients with end-stage renal disease are at increased risk of drug toxicity is reduced activity of the CYP3A enzyme pathway. More... »

PAGES

427-434

Identifiers

URI

http://scigraph.springernature.com/pub.10.1016/s0009-9236(03)00056-0

DOI

http://dx.doi.org/10.1016/s0009-9236(03)00056-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1050158866

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/12732843


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibiotics, Antitubercular", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aryl Hydrocarbon Hydroxylases", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breath Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cytochrome P-450 CYP3A", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Enzyme Induction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Erythromycin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney Failure, Chronic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Liver", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oxidoreductases, N-Demethylating", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenotype", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Protein Synthesis Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rifampin", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dowling", 
        "givenName": "Thomas C.", 
        "id": "sg:person.01074650666.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074650666.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Briglia", 
        "givenName": "Andrew E.", 
        "id": "sg:person.01311023520.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311023520.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fink", 
        "givenName": "Jeffrey C.", 
        "id": "sg:person.014470611312.89", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014470611312.89"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hanes", 
        "givenName": "Donna S.", 
        "id": "sg:person.01255251306.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255251306.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Light", 
        "givenName": "Paul D.", 
        "id": "sg:person.01174411442.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174411442.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stackiewicz", 
        "givenName": "Lucy", 
        "id": "sg:person.01122121315.99", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122121315.99"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Karyekar", 
        "givenName": "Chetan S.", 
        "id": "sg:person.01132164676.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132164676.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Eddington", 
        "givenName": "Natalie D.", 
        "id": "sg:person.0720701511.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720701511.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Weir", 
        "givenName": "Matthew R.", 
        "id": "sg:person.013452757537.22", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013452757537.22"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Henrich", 
        "givenName": "William L.", 
        "id": "sg:person.01112550337.00", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112550337.00"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/0006-2952(84)90451-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000647608"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-2952(84)90451-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000647608"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-200140050-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000972929", 
          "https://doi.org/10.2165/00003088-200140050-00002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-200140050-00002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000972929", 
          "https://doi.org/10.2165/00003088-200140050-00002"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/313548", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003121697"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/j.1875-9114.1998.tb03147.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003751252"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/clpt.1992.174", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003814688", 
          "https://doi.org/10.1038/clpt.1992.174"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/106002809402800303", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005531040"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/106002809402800303", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005531040"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0024-3205(84)90030-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006238852"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0024-3205(84)90030-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006238852"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00005344-198400067-00009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006394194"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/00005344-198400067-00009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006394194"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1525-139x.2000.00065.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006505169"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinte.1982.00340200063016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006738877"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1016/s0009-9236(99)70130-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009415110", 
          "https://doi.org/10.1016/s0009-9236(99)70130-x"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/j.1552-4604.1998.tb05785.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010073598"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1016/s0009-9236(98)90055-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012254725", 
          "https://doi.org/10.1016/s0009-9236(98)90055-8"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.279.15.1200", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018359649"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cpt1974165part1761", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022937647"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0006-291x(84)90723-x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023616961"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/10408449209145319", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029820821"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/archinte.1995.00430180043006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033106954"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/00912700122010023", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035675560"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.2165/00003088-198916040-00001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036734395", 
          "https://doi.org/10.2165/00003088-198916040-00001"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/86882", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040716587", 
          "https://doi.org/10.1038/86882"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/86882", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040716587", 
          "https://doi.org/10.1038/86882"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/j.1875-9114.1998.tb03830.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040917069"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/clpt.1992.17", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043265675", 
          "https://doi.org/10.1038/clpt.1992.17"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/00912700022009251", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049688142"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1254/jjp.68.431", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050132807"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1016/0009-9236(95)90261-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053496085", 
          "https://doi.org/10.1016/0009-9236(95)90261-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1067/mcp.2001.119811", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1058147219", 
          "https://doi.org/10.1067/mcp.2001.119811"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/01.asn.0000017575.50319.77", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060318795"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074548313", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074750911", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082619868", 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-3-0348-7292-8_13", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1089814061", 
          "https://doi.org/10.1007/978-3-0348-7292-8_13"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-05", 
    "datePublishedReg": "2003-05-01", 
    "description": "BACKGROUND: The cytochrome p450 (CYP) oxidative enzyme system, located primarily in the liver and small intestine, is responsible for metabolism and detoxification of numerous endogenous and exogenous substances. The most abundant CYP enzyme, CYP3A, is known to be involved in the metabolism of more than 200 commonly used medications. In experimental models of renal failure, both hepatic function and CYP enzyme content are reduced; however, direct evidence in humans is lacking. Evaluation of drug metabolism in patients with end-stage renal disease is important because these patients use a large number of medications and are at risk of adverse reactions and drug-drug interactions.\nMETHODS: We measured hepatic CYP3A activity at baseline and after rifampin (INN, rifampicin) enzyme induction in 12 patients with end-stage renal disease and 12 healthy, age-matched controls. Hepatic CYP3A phenotype was characterized with the erythromycin breath test, and enzyme induction capacity was evaluated with a short course of rifampin (600 mg/d for 6 days).\nRESULTS: The end-stage renal disease group had 28% lower baseline erythromycin breath test values than controls (P <.05); however, enzyme induction capacity after rifampin administration was similar between groups (P =.70).\nCONCLUSION: The findings suggested that one mechanism by which patients with end-stage renal disease are at increased risk of drug toxicity is reduced activity of the CYP3A enzyme pathway.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1016/s0009-9236(03)00056-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1017409", 
        "issn": [
          "0009-9236", 
          "1532-6535"
        ], 
        "name": "Clinical Pharmacology & Therapeutics", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "5", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "73"
      }
    ], 
    "name": "Characterization of hepatic cytochrome P4503A activity in patients with end\u2010stage renal disease", 
    "pagination": "427-434", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "eef10939efdfbaa1415d6c579be8aec3e8e0c7daf708ff8593d86a4e3049c056"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "12732843"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0372741"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1016/s0009-9236(03)00056-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1050158866"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1016/s0009-9236(03)00056-0", 
      "https://app.dimensions.ai/details/publication/pub.1050158866"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T17:08", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8672_00000274.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://onlinelibrary.wiley.com/doi/10.1016/S0009-9236(03)00056-0/abstract"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1016/s0009-9236(03)00056-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1016/s0009-9236(03)00056-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1016/s0009-9236(03)00056-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1016/s0009-9236(03)00056-0'


 

This table displays all metadata directly associated to this object as RDF triples.

328 TRIPLES      21 PREDICATES      80 URIs      40 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1016/s0009-9236(03)00056-0 schema:about N00720bb3f7764381b1b367aa6f89099a
2 N021151a39e5a46918cb65c51b3ec60a8
3 N0a6c9f1977b648e08ac33b22b5979e87
4 N0d2657b75fa7490e8d83b68cda666d15
5 N46bbc03f5a0c4846951849f5861c2328
6 N51898bcca20b4eceb69e895e1a2e5eb4
7 N52de88ba1d57437bb2e8b171a1427c82
8 N574e147fa6d549049b24b16393a167ad
9 N61fb0eb7d3da4db2ae346788f0d5c2a1
10 N74aae510facb466295e5187d3187a664
11 N770952e59d704669bb5479ede3cd9d2d
12 N7f15938779914ebe99b361cdcd1c0c4e
13 N84abae2655844190a3c858417172aac7
14 Nb8896301a384430a85a7aa9480dbcb4c
15 Nc3bff624c91d419f9483feb1bc3f89f2
16 Ncc3e3f5d35444208962d11510ddd47d0
17 Nd1111a71d9444ad1b39f054c3fa399db
18 Nd3b18e38e26e48439ac23191ff5ab0f3
19 Ne0477c50d08f41e686677139190901bc
20 anzsrc-for:11
21 anzsrc-for:1103
22 schema:author N25aa5a54a8154a7695581fa4f0e1f533
23 schema:citation sg:pub.10.1007/978-3-0348-7292-8_13
24 sg:pub.10.1016/0009-9236(95)90261-9
25 sg:pub.10.1016/s0009-9236(98)90055-8
26 sg:pub.10.1016/s0009-9236(99)70130-x
27 sg:pub.10.1038/86882
28 sg:pub.10.1038/clpt.1992.17
29 sg:pub.10.1038/clpt.1992.174
30 sg:pub.10.1067/mcp.2001.119811
31 sg:pub.10.2165/00003088-198916040-00001
32 sg:pub.10.2165/00003088-200140050-00002
33 https://app.dimensions.ai/details/publication/pub.1074548313
34 https://app.dimensions.ai/details/publication/pub.1074750911
35 https://app.dimensions.ai/details/publication/pub.1082619868
36 https://doi.org/10.1001/archinte.1982.00340200063016
37 https://doi.org/10.1001/archinte.1995.00430180043006
38 https://doi.org/10.1001/jama.279.15.1200
39 https://doi.org/10.1002/cpt1974165part1761
40 https://doi.org/10.1002/j.1552-4604.1998.tb05785.x
41 https://doi.org/10.1002/j.1875-9114.1998.tb03147.x
42 https://doi.org/10.1002/j.1875-9114.1998.tb03830.x
43 https://doi.org/10.1016/0006-291x(84)90723-x
44 https://doi.org/10.1016/0006-2952(84)90451-9
45 https://doi.org/10.1016/0024-3205(84)90030-4
46 https://doi.org/10.1046/j.1525-139x.2000.00065.x
47 https://doi.org/10.1086/313548
48 https://doi.org/10.1097/00005344-198400067-00009
49 https://doi.org/10.1097/01.asn.0000017575.50319.77
50 https://doi.org/10.1177/00912700022009251
51 https://doi.org/10.1177/00912700122010023
52 https://doi.org/10.1177/106002809402800303
53 https://doi.org/10.1254/jjp.68.431
54 https://doi.org/10.3109/10408449209145319
55 schema:datePublished 2003-05
56 schema:datePublishedReg 2003-05-01
57 schema:description BACKGROUND: The cytochrome p450 (CYP) oxidative enzyme system, located primarily in the liver and small intestine, is responsible for metabolism and detoxification of numerous endogenous and exogenous substances. The most abundant CYP enzyme, CYP3A, is known to be involved in the metabolism of more than 200 commonly used medications. In experimental models of renal failure, both hepatic function and CYP enzyme content are reduced; however, direct evidence in humans is lacking. Evaluation of drug metabolism in patients with end-stage renal disease is important because these patients use a large number of medications and are at risk of adverse reactions and drug-drug interactions. METHODS: We measured hepatic CYP3A activity at baseline and after rifampin (INN, rifampicin) enzyme induction in 12 patients with end-stage renal disease and 12 healthy, age-matched controls. Hepatic CYP3A phenotype was characterized with the erythromycin breath test, and enzyme induction capacity was evaluated with a short course of rifampin (600 mg/d for 6 days). RESULTS: The end-stage renal disease group had 28% lower baseline erythromycin breath test values than controls (P <.05); however, enzyme induction capacity after rifampin administration was similar between groups (P =.70). CONCLUSION: The findings suggested that one mechanism by which patients with end-stage renal disease are at increased risk of drug toxicity is reduced activity of the CYP3A enzyme pathway.
58 schema:genre research_article
59 schema:inLanguage en
60 schema:isAccessibleForFree false
61 schema:isPartOf N8a90548d5d244b878b777de476487e09
62 Nda8eb4955ab14735bd448f0745da1d9c
63 sg:journal.1017409
64 schema:name Characterization of hepatic cytochrome P4503A activity in patients with end‐stage renal disease
65 schema:pagination 427-434
66 schema:productId N0b1c9e45c1ee497aaeaa87be1500c557
67 N0cfefe5a2c9a48eb840000501de9c6a4
68 N1b6a33f0ab4b4bd9911a545acd60b3bf
69 N3f2e8780df4145bb9d75a5735d647130
70 N481a7ba9bb40473cb041a24ba985c379
71 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050158866
72 https://doi.org/10.1016/s0009-9236(03)00056-0
73 schema:sdDatePublished 2019-04-10T17:08
74 schema:sdLicense https://scigraph.springernature.com/explorer/license/
75 schema:sdPublisher Nad36a8816d17431b94254be5131c29e3
76 schema:url http://onlinelibrary.wiley.com/doi/10.1016/S0009-9236(03)00056-0/abstract
77 sgo:license sg:explorer/license/
78 sgo:sdDataset articles
79 rdf:type schema:ScholarlyArticle
80 N00720bb3f7764381b1b367aa6f89099a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Breath Tests
82 rdf:type schema:DefinedTerm
83 N021151a39e5a46918cb65c51b3ec60a8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Middle Aged
85 rdf:type schema:DefinedTerm
86 N0a6c9f1977b648e08ac33b22b5979e87 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Oxidoreductases, N-Demethylating
88 rdf:type schema:DefinedTerm
89 N0b1c9e45c1ee497aaeaa87be1500c557 schema:name dimensions_id
90 schema:value pub.1050158866
91 rdf:type schema:PropertyValue
92 N0cfefe5a2c9a48eb840000501de9c6a4 schema:name pubmed_id
93 schema:value 12732843
94 rdf:type schema:PropertyValue
95 N0d2657b75fa7490e8d83b68cda666d15 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Adult
97 rdf:type schema:DefinedTerm
98 N1b6a33f0ab4b4bd9911a545acd60b3bf schema:name readcube_id
99 schema:value eef10939efdfbaa1415d6c579be8aec3e8e0c7daf708ff8593d86a4e3049c056
100 rdf:type schema:PropertyValue
101 N1e93d1be08474a5787c5a787475547d5 schema:name School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA
102 rdf:type schema:Organization
103 N25aa5a54a8154a7695581fa4f0e1f533 rdf:first sg:person.01074650666.36
104 rdf:rest N49ac742dbcd44beaaa85ae2e08c6b701
105 N2b8c61d5021f4b0d8ad25dc2acc98997 schema:name School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA
106 rdf:type schema:Organization
107 N3574c9dbe219402b8a0e3dda8875f684 rdf:first sg:person.01122121315.99
108 rdf:rest Ne5f9058f3e7b47cca788935752a7ed55
109 N3f2e8780df4145bb9d75a5735d647130 schema:name doi
110 schema:value 10.1016/s0009-9236(03)00056-0
111 rdf:type schema:PropertyValue
112 N434c24eb748c4c3c9892ae845812bb6e schema:name School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA
113 rdf:type schema:Organization
114 N46bbc03f5a0c4846951849f5861c2328 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Liver
116 rdf:type schema:DefinedTerm
117 N481a7ba9bb40473cb041a24ba985c379 schema:name nlm_unique_id
118 schema:value 0372741
119 rdf:type schema:PropertyValue
120 N49ac742dbcd44beaaa85ae2e08c6b701 rdf:first sg:person.01311023520.23
121 rdf:rest Nf2da367fcd5b47cbb61f0a4b947f100c
122 N51898bcca20b4eceb69e895e1a2e5eb4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Cytochrome P-450 CYP3A
124 rdf:type schema:DefinedTerm
125 N52de88ba1d57437bb2e8b171a1427c82 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Female
127 rdf:type schema:DefinedTerm
128 N574e147fa6d549049b24b16393a167ad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Aged
130 rdf:type schema:DefinedTerm
131 N5ab4fbe0c0354a2dacbbbaef1053cfa1 rdf:first sg:person.01174411442.54
132 rdf:rest N3574c9dbe219402b8a0e3dda8875f684
133 N61fb0eb7d3da4db2ae346788f0d5c2a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Phenotype
135 rdf:type schema:DefinedTerm
136 N62f182ba32c9405891469117a45d9f86 schema:name School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA
137 rdf:type schema:Organization
138 N69dd200af75d4256aaa3b95ff360e4f0 schema:name School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA
139 rdf:type schema:Organization
140 N74aae510facb466295e5187d3187a664 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
141 schema:name Male
142 rdf:type schema:DefinedTerm
143 N770952e59d704669bb5479ede3cd9d2d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
144 schema:name Kidney Failure, Chronic
145 rdf:type schema:DefinedTerm
146 N798c15669a434f37af6ea0aa19dc72ac rdf:first sg:person.01112550337.00
147 rdf:rest rdf:nil
148 N7a2f6f01d05f41b1a7d30590d704fed4 schema:name School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA
149 rdf:type schema:Organization
150 N7f15938779914ebe99b361cdcd1c0c4e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Enzyme Induction
152 rdf:type schema:DefinedTerm
153 N84abae2655844190a3c858417172aac7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Protein Synthesis Inhibitors
155 rdf:type schema:DefinedTerm
156 N8a90548d5d244b878b777de476487e09 schema:volumeNumber 73
157 rdf:type schema:PublicationVolume
158 N8cbb8691b3944f13bf73c03eb888234c rdf:first sg:person.0720701511.28
159 rdf:rest N8dab520e92674bfcb9b5ec5e9dc6150f
160 N8dab520e92674bfcb9b5ec5e9dc6150f rdf:first sg:person.013452757537.22
161 rdf:rest N798c15669a434f37af6ea0aa19dc72ac
162 N971c561374f9475d91d635598494d888 schema:name School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA
163 rdf:type schema:Organization
164 Na2c3558560be4446aea8ca2fb133561c schema:name School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA
165 rdf:type schema:Organization
166 Na3a2720fba6841abba9a7ac8b97e4539 schema:name School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA
167 rdf:type schema:Organization
168 Nad36a8816d17431b94254be5131c29e3 schema:name Springer Nature - SN SciGraph project
169 rdf:type schema:Organization
170 Nb8896301a384430a85a7aa9480dbcb4c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Rifampin
172 rdf:type schema:DefinedTerm
173 Nc3bff624c91d419f9483feb1bc3f89f2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Humans
175 rdf:type schema:DefinedTerm
176 Ncc3e3f5d35444208962d11510ddd47d0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
177 schema:name Antibiotics, Antitubercular
178 rdf:type schema:DefinedTerm
179 Ncefc0128a07f4b5095d7851e989f1aae rdf:first sg:person.01255251306.02
180 rdf:rest N5ab4fbe0c0354a2dacbbbaef1053cfa1
181 Nd1111a71d9444ad1b39f054c3fa399db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Aryl Hydrocarbon Hydroxylases
183 rdf:type schema:DefinedTerm
184 Nd3b18e38e26e48439ac23191ff5ab0f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Erythromycin
186 rdf:type schema:DefinedTerm
187 Nda8eb4955ab14735bd448f0745da1d9c schema:issueNumber 5
188 rdf:type schema:PublicationIssue
189 Ne0477c50d08f41e686677139190901bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Prospective Studies
191 rdf:type schema:DefinedTerm
192 Ne5f9058f3e7b47cca788935752a7ed55 rdf:first sg:person.01132164676.10
193 rdf:rest N8cbb8691b3944f13bf73c03eb888234c
194 Nf2da367fcd5b47cbb61f0a4b947f100c rdf:first sg:person.014470611312.89
195 rdf:rest Ncefc0128a07f4b5095d7851e989f1aae
196 Nf98ab9967beb48c198f94f5becf59e2d schema:name School of Pharmacy, and the Department of Medicine, Division of Nephrology, School of Medicine, University of Maryland Pharmacokinetics/Biopharmaceutics Laboratory Baltimore Md USA
197 rdf:type schema:Organization
198 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
199 schema:name Medical and Health Sciences
200 rdf:type schema:DefinedTerm
201 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
202 schema:name Clinical Sciences
203 rdf:type schema:DefinedTerm
204 sg:journal.1017409 schema:issn 0009-9236
205 1532-6535
206 schema:name Clinical Pharmacology & Therapeutics
207 rdf:type schema:Periodical
208 sg:person.01074650666.36 schema:affiliation N62f182ba32c9405891469117a45d9f86
209 schema:familyName Dowling
210 schema:givenName Thomas C.
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01074650666.36
212 rdf:type schema:Person
213 sg:person.01112550337.00 schema:affiliation Na2c3558560be4446aea8ca2fb133561c
214 schema:familyName Henrich
215 schema:givenName William L.
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112550337.00
217 rdf:type schema:Person
218 sg:person.01122121315.99 schema:affiliation N69dd200af75d4256aaa3b95ff360e4f0
219 schema:familyName Stackiewicz
220 schema:givenName Lucy
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122121315.99
222 rdf:type schema:Person
223 sg:person.01132164676.10 schema:affiliation N1e93d1be08474a5787c5a787475547d5
224 schema:familyName Karyekar
225 schema:givenName Chetan S.
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01132164676.10
227 rdf:type schema:Person
228 sg:person.01174411442.54 schema:affiliation N2b8c61d5021f4b0d8ad25dc2acc98997
229 schema:familyName Light
230 schema:givenName Paul D.
231 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01174411442.54
232 rdf:type schema:Person
233 sg:person.01255251306.02 schema:affiliation Nf98ab9967beb48c198f94f5becf59e2d
234 schema:familyName Hanes
235 schema:givenName Donna S.
236 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255251306.02
237 rdf:type schema:Person
238 sg:person.01311023520.23 schema:affiliation N434c24eb748c4c3c9892ae845812bb6e
239 schema:familyName Briglia
240 schema:givenName Andrew E.
241 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01311023520.23
242 rdf:type schema:Person
243 sg:person.013452757537.22 schema:affiliation N7a2f6f01d05f41b1a7d30590d704fed4
244 schema:familyName Weir
245 schema:givenName Matthew R.
246 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013452757537.22
247 rdf:type schema:Person
248 sg:person.014470611312.89 schema:affiliation Na3a2720fba6841abba9a7ac8b97e4539
249 schema:familyName Fink
250 schema:givenName Jeffrey C.
251 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014470611312.89
252 rdf:type schema:Person
253 sg:person.0720701511.28 schema:affiliation N971c561374f9475d91d635598494d888
254 schema:familyName Eddington
255 schema:givenName Natalie D.
256 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0720701511.28
257 rdf:type schema:Person
258 sg:pub.10.1007/978-3-0348-7292-8_13 schema:sameAs https://app.dimensions.ai/details/publication/pub.1089814061
259 https://doi.org/10.1007/978-3-0348-7292-8_13
260 rdf:type schema:CreativeWork
261 sg:pub.10.1016/0009-9236(95)90261-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053496085
262 https://doi.org/10.1016/0009-9236(95)90261-9
263 rdf:type schema:CreativeWork
264 sg:pub.10.1016/s0009-9236(98)90055-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012254725
265 https://doi.org/10.1016/s0009-9236(98)90055-8
266 rdf:type schema:CreativeWork
267 sg:pub.10.1016/s0009-9236(99)70130-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1009415110
268 https://doi.org/10.1016/s0009-9236(99)70130-x
269 rdf:type schema:CreativeWork
270 sg:pub.10.1038/86882 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040716587
271 https://doi.org/10.1038/86882
272 rdf:type schema:CreativeWork
273 sg:pub.10.1038/clpt.1992.17 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043265675
274 https://doi.org/10.1038/clpt.1992.17
275 rdf:type schema:CreativeWork
276 sg:pub.10.1038/clpt.1992.174 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003814688
277 https://doi.org/10.1038/clpt.1992.174
278 rdf:type schema:CreativeWork
279 sg:pub.10.1067/mcp.2001.119811 schema:sameAs https://app.dimensions.ai/details/publication/pub.1058147219
280 https://doi.org/10.1067/mcp.2001.119811
281 rdf:type schema:CreativeWork
282 sg:pub.10.2165/00003088-198916040-00001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036734395
283 https://doi.org/10.2165/00003088-198916040-00001
284 rdf:type schema:CreativeWork
285 sg:pub.10.2165/00003088-200140050-00002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000972929
286 https://doi.org/10.2165/00003088-200140050-00002
287 rdf:type schema:CreativeWork
288 https://app.dimensions.ai/details/publication/pub.1074548313 schema:CreativeWork
289 https://app.dimensions.ai/details/publication/pub.1074750911 schema:CreativeWork
290 https://app.dimensions.ai/details/publication/pub.1082619868 schema:CreativeWork
291 https://doi.org/10.1001/archinte.1982.00340200063016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006738877
292 rdf:type schema:CreativeWork
293 https://doi.org/10.1001/archinte.1995.00430180043006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033106954
294 rdf:type schema:CreativeWork
295 https://doi.org/10.1001/jama.279.15.1200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018359649
296 rdf:type schema:CreativeWork
297 https://doi.org/10.1002/cpt1974165part1761 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022937647
298 rdf:type schema:CreativeWork
299 https://doi.org/10.1002/j.1552-4604.1998.tb05785.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1010073598
300 rdf:type schema:CreativeWork
301 https://doi.org/10.1002/j.1875-9114.1998.tb03147.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1003751252
302 rdf:type schema:CreativeWork
303 https://doi.org/10.1002/j.1875-9114.1998.tb03830.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1040917069
304 rdf:type schema:CreativeWork
305 https://doi.org/10.1016/0006-291x(84)90723-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1023616961
306 rdf:type schema:CreativeWork
307 https://doi.org/10.1016/0006-2952(84)90451-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000647608
308 rdf:type schema:CreativeWork
309 https://doi.org/10.1016/0024-3205(84)90030-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006238852
310 rdf:type schema:CreativeWork
311 https://doi.org/10.1046/j.1525-139x.2000.00065.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1006505169
312 rdf:type schema:CreativeWork
313 https://doi.org/10.1086/313548 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003121697
314 rdf:type schema:CreativeWork
315 https://doi.org/10.1097/00005344-198400067-00009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006394194
316 rdf:type schema:CreativeWork
317 https://doi.org/10.1097/01.asn.0000017575.50319.77 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060318795
318 rdf:type schema:CreativeWork
319 https://doi.org/10.1177/00912700022009251 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049688142
320 rdf:type schema:CreativeWork
321 https://doi.org/10.1177/00912700122010023 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035675560
322 rdf:type schema:CreativeWork
323 https://doi.org/10.1177/106002809402800303 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005531040
324 rdf:type schema:CreativeWork
325 https://doi.org/10.1254/jjp.68.431 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050132807
326 rdf:type schema:CreativeWork
327 https://doi.org/10.3109/10408449209145319 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029820821
328 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...